News & Media

Looking for an effective and reliable way to isolate EVs? Consider the AFC – coupled with qEV columns. A combo that is sure to up your EV isolation game.

Everything you need to know about MISEV2023 and how to meet it when publishing your qEV research.

Looking for a versatile tool to add to your research facility’s repertoire? The Exoid has you covered.

Diehl et al., (2023) describe a standardised EV workflow using qEV isolation and TRPS to streamline EV isolation and characterisation protocols.

A wrap-up of publications featuring Tunable Resistive Pulse Sensing technology in Q4 of 2023.

A snapshot of publications built on qEV isolation technology, from the final quarter of 2023.

The qEV100 is used to isolate extracellular vesicles (EVs) from large sample volumes. How does this size exclusion chromatography column stack up against ultracentrifugation?

Introducing the new qEV 20 nm Series, allowing you branch even further into the small end of the size spectrum and isolate more small particles than ever before.

A new Exoid update is here and it is making the measurement of small particles easier and more accurate than ever before.

The International Organization for Standardization has created an ISO standard for Tunable Resistive Pulse Sensing measurement of particle size distribution.

Read about the role of qEV columns in recent stem cell EV discoveries.

A new tier of columns is now available: GMP-ready qEV columns.

If you want the purest EV isolate which qEV column should you pick?

A deep dive into the approaches, considerations and pitfalls of labelling EVs.

A new approach to concentrating EVs after qEV isolation, featuring Magnetic Nanotrap® EV Capture Particles.

You know about extracellular vesicles, sure, but what about the new kids on the block? Exomeres and supermeres are here, and they are making a splash in the world of intercellular communication.

Tunable Resistive Pulse Sensing excels as a method for analysing size, zeta potential and stability of nanomedicines.

What does the future of extracellular vesicle isolation have in store, and how is Izon working towards that? Technology Networks speaks to Hans van der Voorn, CEO at Izon Science.

What lipid nanoparticle measurement data can you get using the Exoid? Let’s find out.

When it comes to yield, purity, expense and time commitment, does size exclusion chromatography or precipitation take the crown for EV isolation?

A brief roundup of findings from 5 studies published in Q2 of 2023 which featured Tunable Resistive Pulse Sensing measurements.

Whatever the end goal of your large-scale EV production, the Exoid can help keep you on track.

When it comes to measuring particle size in the field of nanomedicine, how do TRPS and DLS compare?

A summary of work by Martinelli et al. (2020) who describe the production of extracellular vesicle (EV)-inspired nanoparticles for drug delivery, and used Tunable Resistive Pulse Sensing to characterise the vesicles.

From Arabidopsis thaliana to red cabbage, the field of plant EV (and EV-like nanoparticle) research is a fast-changing world of basic biology and therapeutics. So why is methodology stuck in the past?

When your research relies on knowing the absolute size of the particles, accuracy is essential. Learn how the Exoid is providing high precision data to improve our understanding of particle behaviour.

The collaborative agreement between Izon Science and ABT offers exceptional opportunities to develop solutions that aid in advancing EV research into clinical settings.

The Gen 2 qEV range provides a strong foundation for extracellular vesicle isolation, paving the way towards a future where EVs shape clinical decisions and health outcomes. Here, we share an overview and key resources related to qEV Gen 2 columns.

When it comes to EV isolation for cancer diagnostics, picking the right methodology could be the difference between succeeding in diagnostics versus failing to achieve sufficient specificity and sensitivity. With qEV columns excelling in purity, your biomarker has a stronger chance at standing out amongst the background noise.

Regulations in nanomedicine are lacking, with no global consensus on definitions and a lack of clarity around which attributes are critical to safety. However, some initiatives and guidelines are in place which may provide indications of what to expect in the future.